Skip to main content

Table 6 A comparison between DMTO and some existing diabetes treatment ontologies

From: A mobile health monitoring-and-treatment system based on integration of the SSN sensor ontology and the HL7 FHIR standard

Dimension FASTO DMTO [10] DKOs [67] Chen et al. [68] Chalortham et al. [69] Zhang et al. [70] OntoDiabetic [71]
Purpose Treatment Treatment Treatment Treatment Treatment Treatment Treatment
Type of diabetes T1D T2D NA T2D T2D T2D NA
Available for reuse Yes Yes No No No No No
Based on a unified top-level ontology Yes Yes No No No No No
Encoded using standardized terminology Yes Yes No No No Yes No
Based on OWL 2 and SWRL Yes Yes Yes Yes Yes Yes Yes
Can be utilized in MH environments Yes No No No No No No
Based on an interoperability standard Yes No No No No No No
Decisions based on the whole patient profile Yes Yes Yes Only 6 tests entered by user No Yes Yes
Supports interoperability with EHR distributed systems Yes No No No No No No
Supports real-time patient monitoring based on WBANs Yes No No No No No No
Supports data communication by standards as RESTful API Yes No No No No No No
Handles interoperability with sensor data Yes No No No No No No
Based on standard knowledge (i.e. collected from CPGs) Yes Yes No Yes No Yes Yes
Uses a systematic method for creation Yes Yes No No Yes No No
Delivers complete TPs with drugs, lifestyle, and education Yes Yes No No No Yes No
Models diabetes drugs Yes Yes No Yes No No Yes
Models drugs affecting glucose level Yes Yes No No No No No
Models drug properties Yes Yes No Yes No No No
Models T1D comorbidities Yes Yes Yes No No No Yes
Reuses existing ontologies Yes Yes No No Yes No Yes
Ontology coverage Table 5 [10] NA 18 drugs +6 rules NA NA NA
Models temporal semantics Yes Yes No Yes No No No